Skip to main content

Table 2 Drug class-specific resistance in participants on first and second-line ART regimens

From: Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa

ART regimen

n

NRTI resistance

NNRTI resistance

Major PI resistance

First-line

70

62 (88.6%)

65 (92.9%)

0

Second-line

44

36 (81.6%)

40 (90.9%)

6 (13.6%)

  1. ART antiretroviral therapy, NRTI nucleoside reverse transcriptase inhibitor, NNRTI non-nucleoside reverse transcriptase inhibitor, PI protease inhibitor
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us